(270 days)
K 012226
No
The summary describes a vital parameter monitoring system that registers and calculates standard physiological data. There is no mention of AI, ML, or any advanced analytical techniques beyond basic calculations and data transmission. The focus is on hardware components and standard safety/performance testing.
No.
The device is a monitoring system intended for measuring and displaying vital parameters. It does not provide any therapeutic intervention.
No
The device is described as a "monitoring system" for "vital parameters" and is intended for use in settings like the ICU, recovery room, and operating room. Its function is to register and calculate vital parameters, which are then transmitted for visualization and monitoring. This indicates a role in patient monitoring rather than diagnosing a condition or disease.
No
The device description explicitly states the system comprises a "Parameter Box PB-1000" and a "Visualisation Unit ARGUS PRO," which are hardware components. It also mentions power inputs and connections, further indicating it is not software-only.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states the monitoring of vital parameters such as invasive blood pressure and FIO2. These are physiological measurements taken directly from the patient, not tests performed on samples of bodily fluids or tissues outside the body.
- Device Description: The description details a system for acquiring and displaying vital parameters from the patient.
- Lack of IVD Indicators: There is no mention of analyzing biological samples, reagents, or any processes typically associated with in vitro diagnostics.
The device is a patient monitoring system, which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
The Monitoring System ARGUS PB-2200 is for the monitoring of vital parameters such as: Invasive Blood Pressure: systolic, distolic and mean pressure CO2, etCO2 and CO2ins, main and/or sidestream FIO2. It will extend the functionality of the existing Argus PB -1000 System (K012226). The system comprises the Parameter Box PB-1000 and the Visualisation Unit AR-GUS PRO. The two units are connected via a serial interface. All vital parameters and evaluations are registered and calculated in the PB-1000. This data is then transmitted to the visualisation unit ARGUS PRO or another generally used PC via the serial interface. All data can be shown and monitored on the ARGUS PRO. The PB-1000 operated using an internal battery and an external power input (RS 232/12V), which is, like the data transmission, completely separate from the visualisation unit. The ARGUS PRO is powered via the normal mains connection 230V/110V. The system is intended for use in the Intensive Care Unit, in the Recovery Room, in the Operation Room and during hospital internal transport.
Product codes
DSK
Device Description
The Monitoring System ARGUS PB-2200 is for the monitoring of vital parameters such as: Invasive Blood Pressure: systolic, distolic and mean pressure CO2, etCO2 and CO2ins, main and/or sidestream FIO2. It will extend the functionality of the existing Argus PB -1000 System (K012226). The system comprises the Parameter Box PB-1000 and the Visualisation Unit AR-GUS PRO. The two units are connected via a serial interface. All vital parameters and evaluations are registered and calculated in the PB-1000. This data is then transmitted to the visualisation unit ARGUS PRO or another generally used PC via the serial interface. All data can be shown and monitored on the ARGUS PRO. The PB-1000 operated using an internal battery and an external power input (RS 232/12V), which is, like the data transmission, completely separate from the visualisation unit. The ARGUS PRO is powered via the normal mains connection 230V/110V.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Intensive Care Unit, Recovery Room, Operation Room and during hospital internal transport.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests:
- Electrical Safety and Reliability: The device has been tested to be in accordance with the following standards: EN 60601-1:1990, EN 60601-1-1:1993, EN 60601-1-2: Electromagnetic Compatibility Test, Electrostatic Discharge, Radio Frequency Electromagnetic Field, Fast Transients. EN 60601-1-4:1996 Collateral Standard: Programmable electrical medical systems. EN 60601-2-34:1995 Particular requirements for the safety of the blood pressure monitoring equipment. All tests are passed.
- Data related to software quality: SCHILLER has reviewed its software development process following the quideline "reviewer guidance for computer controlled medical devices undergoing 510 (k) review". Device software requirements, software structure chart, software development, software revision/ modification, software identification, software verification, validation and testing are described in the data attached.
Clinical Tests: n.a.
Conclusions from Tests: The fulfilling of the above standards ensures the safety and effectiveness of the submitted device. We consider the submitted device to be as safe and effective as the Predicate ARGUS PB-1000 System Device. (K 012226)
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K 012226
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1110 Blood pressure computer.
(a)
Identification. A blood pressure computer is a device that accepts the electrical signal from a blood pressure transducer amplifier and indicates the systolic, diastolic, or mean pressure based on the input signal.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows a handwritten text string that appears to be a combination of letters and numbers. The string reads 'K033738' on the first line, and 'P 1/3' on the second line. The handwriting is somewhat rough, and the characters are not perfectly formed.
510 K Summary
AUG 2 4 2004
according to 21 CFR 807.92
- A1 Address
SCHILLER AG Altgasse 68 CH-6341 Baar Switzerland
| Contact Name: | Mr. Markus Buetler |
|---|---|
| Tel: | 001 41 41 766 4252 |
| Date: | 21.th November 2003 |
- A2 Device Name
| 1. Trade Name: | ARGUS PB-2200 |
|---|---|
| 2. Common Name: | Monitoring System |
- A3 Legally Marketed Device Legally Marketed Device to which this submitted device is compared:
ARGUS PB-1000 System K 012226
A4 Intended Use
The Monitoring System ARGUS PB-2200 is for the monitoring of vital parameters such as:
Invasive Blood Pressure: systolic, distolic and mean pressure CO2, etCO2 and CO2ins, main and/or sidestream FIO2
It will extend the functionality of the existing Argus PB -1000 System (K012226) The system comprises the Parameter Box PB-1000 and the Visualisation Unit AR-GUS PRO. The two units are connected via a serial interface.
All vital parameters and evaluations are registered and calculated in the PB-1000. This data is then transmitted to the visualisation unit ARGUS PRO or another generally used PC via the serial interface. All data can be shown and monitored on the ARGUS PRO.
The PB-1000 operated using an internal battery and an external power input (RS 232/12V), which is, like the data transmission, completely separate from the visualisation unit. The ARGUS PRO is powered via the normal mains connection 230V/110V.
The system is intended for use in the Intensive Care Unit, in the Recovery Room, in the Operation Room and during hospital internal transport.
1
KO 33729
P.L.
Table of Comparison A5
| | Argus PB-1000 System
(K012226) | ARGUS PB-2200 |
|-------------------------------------------------------------------------------------------|-------------------------------------------|-------------------|
| Dimensions: | 210x115x45mm | 210x115x64.5mm 1) |
| Weight: | 980 g | 1200g 2) |
| Environmental Conditions:
Operating temperature | +10° - 40° C | same |
| Storage temperature | -10° - +50° C | same |
| Relative humidity | 25% - 95%
(non condensing) | same |
| Electrostatic Discharge /
Electromagnetic Compatibility:
ESD | EN 60601-1-2 | same |
| | Fully functional below 4 kV
(Open Air) | same |
| | No damage below 8 kV (Open
Air) | same |
| Radiated Emissions | Less than 30 dB Microvolts | same |
| Radiated Immunity | Less than 3 Volts per meter | same |
| Safety Standards
Safety of Medical Electrical Equipment
part1. General requirements | EN 60601-1:1990 | same |
| Safety requirements for medical
systems | EN 60601-1-1:1993 | same |
| Safety requirements for programmable
electrical medical systems | EN 60601-1-4:1996 | same |
| Requirements for the safety of the
blood pressure monitoring equipment | EN 60601-2-34:1995 | same |
Discussion of Differences:
None of the above differences (1 or 2) can be considered as safety relevant differences.
We consider the submitted device to be as safe and effective as the Predicate ARGUS PB-1000 System (K012226) device.
2
Non-Clinical Tests B1
- Electrical Safety and Reliability
The device has been tested to be in accordance with the following standards:
EN 60601-1:1990: Safety of Medical Electrical Equipment part 1, General requirements.
EN 60601-1-1:1993 Safety requirements for medical electrical systems. EN 60601-1-2: Electromagnetic Compatibility Test, Electrostatic Discharge, Radio Frequency Electromagnetic Field, Fast Transients.
EN 60601-1-4:1996 Collateral Standard: Programmable electrical medical systems.
EN 60601-2-34:1995 Particular requirements for the safety of the blood pressure monitoring equipment.
All tests are passed.
-
- Data related to software quality
SCHILLER has reviewed its software development process following the quideline
- Data related to software quality
" reviewer guidance for computer controlled medical devices undergoing 510 (k) review". Device software requirements, software structure chart, software development, software revision/ modification, software identification, software verification, validation and testing are described in the data attached.
-
B2 Clinical Tests
n.a. -
Conclusions from Tests B3
The fulfilling of the above standards ensures the safety and effectiveness of the submitted device. We consider the submitted device to be as safe and effective as the Predicate ARGUS PB-1000 System Device. (K 012226)
Date: 21.11.2003
K. R. Ze.
Martin Roth
Markus Buetler Quality Assurance Manager SCHILLER AG
3
Image /page/3/Picture/11 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an emblem featuring a stylized depiction of three wavy lines, resembling a bird or a symbol representing health and human services.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 4 2004
Mr. Markus Buetler Quality Assurance Manager SCHILLER AG Altgasse 68 CH-6341 Baar Switzerland
Re: K033738
Trade Name: ARGUS PB-2200 Patient Monitoring System Regulation Number: 21 CFR 870.1110 Regulation Name: Blood Pressure Computer Regulatory Class: Class II (two) Product Code: DSK Dated: August 2, 2004 Received: August 4, 2004
Dear Mr. Buetler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Markus Buetler
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
N.W.R.S. Oplien
Barry D. Zuckerman, M.D.
Bram D. Zuckern Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K033738 _
Device Name: Monitoring System ARGUS PB-2200
Indications For Use:
The monitoring system ARGUS PB-2200 is for the monitoring of vital parameters such as:
Invasive blood pressure: systolic, diastolic and mean pressure
s and controller Brings and/or sidestream Invasive blood pressure. Systems, main and/or sidestream FIO2
lt will extend the functionality of the existing Argus PB-1000 system (K0122Z6).
The function and the promoter her PB-1000 and the visualisation unit AR It will extend the functionality of the existing Algust PB-1000 (PB-100) (PB-100)
The system comprises the parameter box PB-1000 and the visualisation unit ARGUS
(PBS) and th
The system compilses the parcined via a serial interface. PRO. The two units are connected via a serial intenated and calculated in the PB-2200. This All vital parameters and evaluations are registered and calouaced manager generally used
data is then transmitted to the visualisation unit ARGUS PRO or another generally us data is then transmitted to the visuallsation und monitored on the ARGUS PRO.
PC via the serial interface. All data can be shown and monitored on the ARGUS PRO. PC via the serial interface. All data can be snown and monecessed power input (RS
The PB-2200 is operated using an internal battery and an external power input (RS
e and the The PB-2200 is operated using an internal battery alle an and the manate from the 232/12V), which is, like the data transmission, completely sop
visualisation unit. The ARGUS PRO is powered via the normal mains connection
230V/110V.
The system is intended for use in the intensive care unit, in the recovery room, in the The system is intended for ass internal transports.
SCHILLER AG
Altgasse 68
CH-6341 Baar/Switzerland
Prescription Use X
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(Please do not WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nake. Spleen to B, Page 1 of 1
(Division Sian-Off) Jivision of Cardiovascular Devices
510(k) Number KD33738